Esophageal Cancer News

Proton Beam Therapy May Improve Outcomes for Esophageal Cancer (January 23, 2017)

Currently a standard treatment for several gastrointestinal cancers (GI) combines the use of chemotherapy and radiation followed by surgical resection. Radiation may be part of the treatment strategy for select cancers of the esophagus, anus, rectum,... Continue Reading

Should HER2 Testing Be Routinely Performed in Patients with Gastric Cancer? (December 8, 2016)

The short answer is yes! New evidence-based guidelines for human epidermal growth factor receptor 2 (HER2) testing in advanced gastric and gastroesophageal adenocarcinoma (GEA) have been released jointly by the College of American Pathologists (CAP),... Continue Reading

It’s GERD Awareness Week–November 20th (November 20, 2016)

It’s that time of year again when there is a tendency to overindulge in a mélange of delicious foods. Although many people may only suffer discomfort from over eating, another group of people suffer from the far more troublesome and chronic disorder... Continue Reading

Another Study Confirms That Daily Aspirin Lowers Risk of Colorectal & Other GI Tract Cancers (May 9, 2016)

The regular use of aspirin significantly reduces the overall risk of cancer, especially colorectal and other gastrointestinal tract cancers, according to a study published in JAMA Oncology.1 The recent report supports the results of previous clinical... Continue Reading

Patients Rising, Launched to Fight for Access to Vital Therapies and Services for Patients with Life-Threatening Diseases (August 25, 2015)

Patient advocacy veterans Jonathan and Terry Wilcox today announced the launch of a new not-for-profit organization, Patients Rising. This patient advocacy organization will educate, advocate and communicate the importance of access to vital therapies... Continue Reading

Regular Screening of Barrett’s Esophagus Patients Improves Rate of Early Cancer Detection (May 12, 2015)

Patients with Barrett’s esophagus who undergo regular exams have an improved chance that precancerous changes and esophageal cancer will be detected early. These findings were published in the journal Gut. Barrett’s esophagus is a pre-cancerous condition... Continue Reading

Cytosponge Offers Minimally Invasive Screening Option for Barrett’s Esophagus (March 26, 2015)

Screening for Barrett’s esophagus with a new device called a Cytosponge is accurate compared to endoscopy but less expensive and easier on patients. These findings were reported in the journal PLoS Medicine. Barrett’s esophagus is a pre-cancerous... Continue Reading

AMG 337 MET Inhibitor Produces Impressive, Rapid Response in Gastric and Esophageal Cancers (February 12, 2015)

AMG 337 is a novel small-molecule MET inhibitor that appears to show promise in the treatment of MET-amplified gastroesophageal junction, gastric, and esophageal cancers. MET inhibitors are a class of small molecules that inhibit the enzymatic activity... Continue Reading

Esophageal Cancer Survival Improved Using Targeted Therapy Developed in Lung Cancer (December 4, 2014)

Targeted therapy commonly used in lung cancer improves survival of esophageal cancer patients according to clinical trial results recently presented at the National Cancer Research Institute (NCRI) Cancer Conference in the UK. The esophagus is a muscular... Continue Reading

FDA Approves Cyramza™ in Combination With Paclitaxel for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (November 13, 2014)

(CancerConnect) The U.S. Food and Drug Administration(FDA) has approved Cyramza™ (ramucirumab) for use in combination with paclitaxel for the treatment of patients with advanced gastric or gastroesophageal junction adenocarcinoma. Cyramza was approved... Continue Reading

Latest Esophageal Cancer News By Stage


Barrett's Esophagus Esophageal Cancer

Regular Screening of Barrett’s Esophagus Patients Improves Rate of Early Cancer Detection (May 12, 2015)

Patients with Barrett’s esophagus who undergo regular exams have an improved chance that precancerous changes and esophageal cancer will be detected early. These findings were published in the journal Gut. Barrett’s esophagus is a pre-cancerous condition... Continue Reading

Radiofrequency Ablation in Barrett’s Esophagus May Prevent Esophageal Cancer (April 15, 2015)

Treatment of Barrett’s esophagus with radiofrequency ablation appears to keep the condition from progressing to esophageal cancer. These findings were published in the Journal of the American Medical Association. Barrett’s esophagus is a pre-cancerous... Continue Reading

Cytosponge Offers Minimally Invasive Screening Option for Barrett’s Esophagus (March 26, 2015)

Screening for Barrett’s esophagus with a new device called a Cytosponge is accurate compared to endoscopy but less expensive and easier on patients. These findings were reported in the journal PLoS Medicine. Barrett’s esophagus is a pre-cancerous... Continue Reading

More Barrett's Esophagus Esophageal Cancer

Screening/Prevention Esophageal Cancer

It’s GERD Awareness Week–November 20th (November 20, 2016)

It’s that time of year again when there is a tendency to overindulge in a mélange of delicious foods. Although many people may only suffer discomfort from over eating, another group of people suffer from the far more troublesome and chronic disorder... Continue Reading

Regular Screening of Barrett’s Esophagus Patients Improves Rate of Early Cancer Detection (May 12, 2015)

Patients with Barrett’s esophagus who undergo regular exams have an improved chance that precancerous changes and esophageal cancer will be detected early. These findings were published in the journal Gut. Barrett’s esophagus is a pre-cancerous condition... Continue Reading

Radiofrequency Ablation in Barrett’s Esophagus May Prevent Esophageal Cancer (April 15, 2015)

Treatment of Barrett’s esophagus with radiofrequency ablation appears to keep the condition from progressing to esophageal cancer. These findings were published in the Journal of the American Medical Association. Barrett’s esophagus is a pre-cancerous... Continue Reading

Scientific Review Suggests Aspirin Significantly Cuts Cancer Rates (August 18, 2014)

A recent review of several studies confirms that taking a small daily dose of aspirin significantly reduces the risk of developing – or dying from several kinds of cancer.(1) Several clinical studies have suggested that aspirin can reduce the risk... Continue Reading

New Analysis Suggests Possible Increase in Esophageal Cancer Risk Among Users of Oral Bisphosphonates (September 14, 2010)

A new analysis of the UK General Practice Research Database suggests that oral bisphosphonates (drugs commonly used to prevent or treat osteoporosis) may increase the risk of esophageal. These results—published in the British Medical Journal—differ... Continue Reading

More Screening/Prevention Esophageal Cancer

Stage IV/Recurrent Esophageal Cancer

Proton Beam Therapy May Improve Outcomes for Esophageal Cancer (January 23, 2017)

Currently a standard treatment for several gastrointestinal cancers (GI) combines the use of chemotherapy and radiation followed by surgical resection. Radiation may be part of the treatment strategy for select cancers of the esophagus, anus, rectum,... Continue Reading

Patients Rising, Launched to Fight for Access to Vital Therapies and Services for Patients with Life-Threatening Diseases (August 25, 2015)

Patient advocacy veterans Jonathan and Terry Wilcox today announced the launch of a new not-for-profit organization, Patients Rising. This patient advocacy organization will educate, advocate and communicate the importance of access to vital therapies... Continue Reading

AMG 337 MET Inhibitor Produces Impressive, Rapid Response in Gastric and Esophageal Cancers (February 12, 2015)

AMG 337 is a novel small-molecule MET inhibitor that appears to show promise in the treatment of MET-amplified gastroesophageal junction, gastric, and esophageal cancers. MET inhibitors are a class of small molecules that inhibit the enzymatic activity... Continue Reading

Esophageal Cancer Survival Improved Using Targeted Therapy Developed in Lung Cancer (December 4, 2014)

Targeted therapy commonly used in lung cancer improves survival of esophageal cancer patients according to clinical trial results recently presented at the National Cancer Research Institute (NCRI) Cancer Conference in the UK. The esophagus is a muscular... Continue Reading

FDA Approves Cyramza™ in Combination With Paclitaxel for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (November 13, 2014)

(CancerConnect) The U.S. Food and Drug Administration(FDA) has approved Cyramza™ (ramucirumab) for use in combination with paclitaxel for the treatment of patients with advanced gastric or gastroesophageal junction adenocarcinoma. Cyramza was approved... Continue Reading

More Stage IV/Recurrent Esophageal Cancer

Stages I-III Esophageal Cancer

Proton Beam Therapy May Improve Outcomes for Esophageal Cancer (January 23, 2017)

Currently a standard treatment for several gastrointestinal cancers (GI) combines the use of chemotherapy and radiation followed by surgical resection. Radiation may be part of the treatment strategy for select cancers of the esophagus, anus, rectum,... Continue Reading

Chemoradiotherapy plus Surgery Improves Esophageal Cancer Survival (July 19, 2010)

Among patients with cancer of the esophagus or esophagogastric junction, treatment with chemotherapy and radiation therapy prior to surgery resulted in better overall survival than surgery alone. The results of this Phase III clinical trial were presented... Continue Reading

More Stages I-III Esophageal Cancer